Anna Czege is special counsel in the firm's Corporate & Business Transactions practice group. Anna has two decades of experience practicing general corporate law and advises public and private companies on mergers & acquisitions, securities law, and corporate governance.
- Represented FOXO Technologies Inc., a technology company applying epigenetic science and AI to modernize the life insurance industry, in their merger with special purpose acquisition company (SPAC) Delwinds Acquisition Corp. FOXO is now publicly traded on the NYSE under ticker symbol ‘FOXO.'
- Represented Peraso, Inc., a world leader in the development of 5G mmWave silicon, in their Technology License and Patent Assignment Agreement with Intel Corporation.
- Represented the Benchmark Company, the sole book-running manager for a $6.375 Million Initial Public Offering and NASDAQ listing with Heart Test Laboratories, Inc. (NASDAQ: HSCS; HSCSW), a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG’s clinical usefulness.